# Stoke Therapeutics, Inc.: Form 8-K, filed Sep 25, 2026

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: 8-K
- Filed: 2026-09-25
- Accepted by EDGAR: Sep 25, 2026, 16:05 ET
- Period: 2026-09-22
- Accession: 0001193125-26-402820
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000119312526402820/d136438d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000119312526402820/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000119312526402820/d136438d8k.htm

Filed Sep 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-402820. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.